# T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

> **NCT00089180** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 100 (actual)

## Conditions studied

- Actinic Keratosis
- Basal Cell Carcinoma of the Skin
- Recurrent Skin Cancer
- Squamous Cell Carcinoma of the Skin

## Interventions

- **DRUG:** liposomal T4N5 lotion
- **OTHER:** placebo
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00089180
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089180, "T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00089180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
